(The JAMA Network Journals) In a study appearing in the Dec. 20 issue of JAMA, Anna Wald, M.D., M.P.H., of the University of Washington & Fred Hutchinson Cancer Research Center, Seattle, and colleagues compared the medications pritelivir and valacyclovir for reducing genital herpes simplex virus shedding and lesions in persons with recurrent genital herpes.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2hPXPNY
No comments:
Post a Comment